rs752914124
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000199.5(SGSH):c.1272_1282delCAAGGACCTCC(p.Tyr424fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000691 in 1,461,730 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000199.5 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250606Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135776
GnomAD4 exome AF: 0.0000691 AC: 101AN: 1461730Hom.: 0 AF XY: 0.0000646 AC XY: 47AN XY: 727156
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-A Pathogenic:8
- -
- -
Variant summary: SGSH c.1272_1282del11 (p.Tyr424X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have not been classified as pathogenic by our laboratory but have been reported in the HGMD database with a reported phenotype of Sanfillipo syndrome A. The variant allele was found at a frequency of 4e-06 in 250606 control chromosomes. c.1272_1282del11 has been reported in the literature in individuals affected with Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome A) (example, Scott_1997, Weber_1997). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
- -
- -
This sequence change creates a premature translational stop signal (p.Tyr424*) in the SGSH gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 79 amino acid(s) of the SGSH protein. This variant is present in population databases (rs752914124, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with SGSH-related conditions (PMID: 7493035, 27590925). ClinVar contains an entry for this variant (Variation ID: 287037). This variant disrupts a region of the SGSH protein in which other variant(s) (p.Trp471*) have been determined to be pathogenic (internal data). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
The c.1272_1282del11 variant in the SGSH gene has been reported previously in association with Sanfilippo Syndrome A, also known as MPS IIIA (Scott et al., 1995; Truxal et al., 2016). It is reported as pathogenic in ClinVar by a different clinical laboratory, but additional evidence is not available (ClinVar SCV000340680.2; Landrum et al., 2016). The c.1272_1282del11 variant causes a frameshift, changing codon Tyrosine 424 to a premature Stop codon, which eliminates the last 79 amino acids from the protein, and is denoted p.Tyr424Ter. This variant is predicted to cause loss of normal protein function through protein truncation. The c.1272_1282del11 variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret c.1272_1282del11 as a pathogenic variant. -
Diarrhea;C0028738:Nystagmus;C0557874:Global developmental delay;C0854723:Retinal dystrophy;C1301509:Severely reduced visual acuity;C1836830:Developmental regression;C1836923:Gastrointestinal dysmotility Pathogenic:1
- -
Inborn genetic diseases Pathogenic:1
The c.1272_1282del11 (p.Y424*) alteration, located in exon 8 (coding exon 8) of the SGSH gene, consists of a deletion of 11 nucleotides from position 1272 to 1282, causing a translational frameshift with a predicted alternate stop codon after amino acids. This alteration occurs at the 3' terminus of the SGSH gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 15.5% of the protein. However, premature stop codons are typically deleterious in nature, the impacted region is critical for protein function, and a significant portion of the protein is affected (Ambry internal data). Based on data from gnomAD, this allele has an overall frequency of <0.001% (1/250606) total alleles studied. The highest observed frequency was <0.001% (1/113066) of European (non-Finnish) alleles. This variant has been identified in conjunction with other SGSH variants in individuals with reduced enzyme activity and/or a diagnosis of mucopolysaccharidosis type IIIA (Héron, 2011; Truxal, 2016; Sahajpal, 2023). Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at